← The Wire
UTHRNasdaq
UNITED THERAPEUTICS Corp
Pharmaceutical Preparations · DE · CIK 1082554
Develops and sells therapies for serious diseases and innovative organ manufacturing technologies
red 8-K · 90d⚡ Elevated coverage
$23.17B
Market cap
$544.92
Last close
+0.4%
1D
+1.2%
5D
420K
Volume
Price · last 39 sessions-6.2%
May 4L $536.59 · H $596.76Jun 29
69
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteJun 29, 20268-KResults of OperationsMay 6, 202610-Q10-QMay 6, 2026DEFA14ADEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALSApr 29, 2026DEF 14ADEFINITIVE PROXY STATEMENTApr 29, 20268-KCompany UpdateMar 30, 20268-KMaterial Agreement · Reg FD DisclosureMar 9, 20268-KReg FD DisclosureMar 2, 20268-KResults of OperationsFeb 25, 202610-K10-KFeb 25, 20268-KExecutive Change · Bylaw AmendmentJan 22, 20268-KResults of OperationsOct 29, 202510-Q10-QOct 29, 20258-KCompany UpdateSep 2, 20258-KMaterial Agreement · Reg FD DisclosureAug 1, 20258-KResults of OperationsJul 30, 202510-Q10-QJul 30, 20258-KExecutive Change · Shareholder VoteJun 27, 20258-KResults of OperationsApr 30, 202510-Q10-QApr 30, 2025DEFA14ADEFA14AApr 29, 2025DEF 14ADEFINITIVE PROXY STATEMENTApr 29, 20258-KMaterial Agreement · Agreement TerminatedApr 28, 20258-KResults of OperationsFeb 26, 202510-K10-KFeb 26, 20258-KReg FD DisclosureJan 13, 20258-KResults of OperationsOct 30, 202410-Q10-QOct 30, 20248-KResults of OperationsJul 31, 202410-Q10-QJul 31, 20248-KExecutive Change · Shareholder VoteJun 27, 20248-KResults of OperationsMay 1, 202410-Q10-QMay 1, 2024DEFA14ADEFA14AApr 29, 2024DEF 14ADEFINITIVE PROXY STATEMENTApr 29, 20248-KMaterial Agreement · New Debt / ObligationMar 29, 20248-KMaterial Agreement · Reg FD DisclosureMar 25, 20248-KCompany UpdateFeb 27, 20248-KResults of Operations · Reg FD DisclosureFeb 21, 202410-K10-KFeb 21, 2024SC 13DSC 13DDec 22, 20238-KCompany UpdateDec 20, 20238-KCompany UpdateNov 29, 20238-KResults of OperationsNov 1, 202310-Q10-QNov 1, 20238-KResults of OperationsAug 2, 202310-Q10-QAug 2, 20238-KCompany UpdateJul 24, 20238-K/AShareholder VoteJul 14, 20238-KExecutive Change · Shareholder VoteJun 28, 20238-KResults of OperationsMay 3, 202310-Q10-QMay 3, 2023DEFA14ADEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALSApr 28, 2023DEF 14ADEFINITIVE PROXY STATEMENTApr 28, 20238-KBylaw AmendmentApr 21, 20238-KMaterial Agreement · New Debt / ObligationMar 31, 20238-KResults of OperationsFeb 22, 202310-K10-KFeb 22, 2023SC 13GSEC SCHEDULE 13GFeb 6, 2023SC 13GSCHEDULE 13GFeb 3, 20238-KReg FD DisclosureJan 9, 20238-KResults of OperationsNov 2, 202210-Q10-QNov 2, 20228-KCompany UpdateOct 11, 20228-KCompany UpdateSep 20, 20228-KCompany UpdateSep 1, 20228-KResults of OperationsAug 3, 202210-Q10-QAug 3, 20228-KExecutive Change · Shareholder VoteJun 28, 2022
Insider Activity
In the 90 days to Mar 30, 2026: 9 sold $236.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 30, 2026 | Rothblatt Martine AChairperson & CEO | Sell | 1,790 | $588.33 | $1.1M |
| Mar 30, 2026 | Rothblatt Martine AChairperson & CEO | Sell | 1,734 | $589.18 | $1.0M |
| Mar 30, 2026 | Edgemond JamesCFO AND TREASURER | Sell | 1,487 | $588.42 | $875K |
| Mar 30, 2026 | Rothblatt Martine AChairperson & CEO | Sell | 1,346 | $587.34 | $791K |
| Mar 30, 2026 | Causey ChristopherDirector | Sell | 1,300 | $604.64 | $786K |
| Mar 30, 2026 | Edgemond JamesCFO AND TREASURER | Sell | 1,196 | $589.23 | $705K |
| Mar 30, 2026 | Rothblatt Martine AChairperson & CEO | Sell | 1,068 | $590.32 | $630K |
| Mar 30, 2026 | Edgemond JamesCFO AND TREASURER | Sell | 1,026 | $590.36 | $606K |
| Mar 30, 2026 | Edgemond JamesCFO AND TREASURER | Sell | 860 | $587.35 | $505K |
| Mar 30, 2026 | Edgemond JamesCFO AND TREASURER | Sell | 790 | $599.82 | $474K |
| Mar 30, 2026 | Edgemond JamesCFO AND TREASURER | Sell | 770 | $604.64 | $466K |
| Mar 30, 2026 | Rothblatt Martine AChairperson & CEO | Sell | 602 | $591.24 | $356K |
| Mar 30, 2026 | Edgemond JamesCFO AND TREASURER | Sell | 500 | $595.91 | $298K |
| Mar 30, 2026 | Edgemond JamesCFO AND TREASURER | Sell | 480 | $594.74 | $285K |
| Mar 30, 2026 | Edgemond JamesCFO AND TREASURER | Sell | 481 | $591.26 | $284K |
| Mar 30, 2026 | Edgemond JamesCFO AND TREASURER | Sell | 437 | $586.27 | $256K |
| Mar 30, 2026 | Edgemond JamesCFO AND TREASURER | Sell | 417 | $602.53 | $251K |
| Mar 30, 2026 | Rothblatt Martine AChairperson & CEO | Sell | 400 | $594.61 | $238K |
| Mar 30, 2026 | Rothblatt Martine AChairperson & CEO | Sell | 354 | $586.07 | $207K |
| Mar 30, 2026 | Rothblatt Martine AChairperson & CEO | Sell | 320 | $595.80 | $191K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
⚡ Elevated coverageCoverage (30d): 1 reputable article · skews ▲ positive.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance